| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $77.0M | -33.8% |
| SG&A Expense | $23.9M | -8.6% |
| Operating Income | -$104.0M | +27.0% |
| Interest Expense | $1.6M | -7.3% |
| Pre-tax Income | -$101.7M | +24.6% |
| Income Tax | $0 | — |
| Net Income | -$101.7M | +24.6% |
| EPS (Basic) | -$1.90 | +26.4% |
| EPS (Diluted) | -$1.90 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.4M | -6.8% |
| Short-term Investments | $28.4M | -74.2% |
| Current Assets | $50.7M | -62.2% |
| Total Assets | $59.0M | -60.0% |
| Current Liabilities | $24.6M | +32.7% |
| Long-term Debt | $10.2M | -4.1% |
| Total Liabilities | $33.1M | -3.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.1M | +31.0% |
| Capital Expenditures | $212K | -52.6% |
| Investing Cash Flow | $82.6M | -4.3% |
| Financing Cash Flow | $362K | -98.8% |
| Free Cash Flow | -$84.4M | +31.1% |
| +26.4% |
| Stockholders' Equity |
| $26.0M |
| -77.1% |